Prolonged Sitting on Responses to Short-Term Exercise Training

Metabolic Syndrome Clinical Trial

Official title:

Effect of Prolonged Sitting on Metabolic and Cardiovascular Responses to Short-Term Exercise Training

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03352063
• Other study ID #: 2017-07-0074
• Status: Completed
• Phase: N/A
• Start date: July 17, 2018
• Est. completion date: May 30, 2020

Study information

• Verified date: September 2021
• Source: University of Texas at Austin
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Prolonged sitting has been shown to effect the response to a high fat tolerance test (HFTT) after acute exercise. This study will evaluate the effect of prolonged sitting on response to a HFTT after a short term training period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: May 30, 2020
• Est. primary completion date: April 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• 18 to 35 years

Exclusion Criteria:

• cardiovascular problems (e.g. pre-existing heart issues, coronary artery disease, hypertension, etc.)
• respiratory problems
• musculoskeletal problems that prevent prolonged sitting or exercise
• obesity
• susceptibility to fainting
• pregnancy

Related Conditions & MeSH terms

• Atherosclerosis
• Metabolic Syndrome

Intervention

Behavioral:
• Prolonged sitting with exercise
Subjects will commit to sitting more than 11 hours per day and taking less than 5000 steps per day while participating in exercise training.
• Active walking with exercise.
Subjects will commit to sitting less than 5 hours per day and taking more than 10000 steps per day while participating in exercise training.

Locations

Country	Name	City	State
United States	University of Texas at Austin Human Performance Laboratory	Austin	Texas

Sponsors (1)

Lead Sponsor	Collaborator
University of Texas at Austin

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Plasma Triglycerides	Areas under the curve for triglyceride concentration will be calculated for hourly samples from a 6-hour lipid tolerance test	6 hours
Secondary	Plasma Insulin	Areas under the curve for insulin concentration will be calculated for hourly samples from a 6-hour lipid tolerance test	6 hours
Secondary	Plasma glucose	Areas under the curve for glucose concentration will be calculated for hourly samples from a 6-hour lipid tolerance test	6 hours